Management of Pre-eclampsia
The management of pre-eclampsia requires urgent hospitalization for assessment, close maternal and fetal monitoring, blood pressure control, seizure prophylaxis, and timely delivery based on disease severity and gestational age. 1
Diagnosis and Initial Assessment
- Pre-eclampsia is diagnosed by new-onset hypertension (≥140/90 mmHg) after 20 weeks of gestation with proteinuria or evidence of end-organ damage 1, 2
- All women with pre-eclampsia should be hospitalized initially to confirm diagnosis, assess severity, and monitor progression 1, 3
- Maternal monitoring should include:
- Blood pressure measurements every 4 hours (more frequently if severe) 1
- Clinical assessment including evaluation for clonus and neurological symptoms 1
- At least twice weekly blood tests for hemoglobin, platelet count, liver enzymes, and renal function including uric acid 1, 4
- Repeated assessment for proteinuria if not already present 1
Blood Pressure Management
Severe hypertension (>160/110 mmHg) requires urgent treatment in a monitored setting using: 1
For non-severe hypertension (≥140/90 mmHg), treat with oral antihypertensives aiming for target diastolic BP of 85 mmHg and systolic BP between 110-140 mmHg 1
Seizure Prevention with Magnesium Sulfate
Magnesium sulfate should be administered for convulsion prophylaxis in women with: 1
Magnesium sulfate dosing for pre-eclampsia/eclampsia: 5
Fluid Management
- Limit total fluid intake to 60-80 mL/hour to avoid pulmonary edema 1, 4
- Aim for euvolemia; avoid "running dry" as this increases risk of acute kidney injury 1
- Avoid NSAIDs for postpartum analgesia, especially with renal dysfunction 1
Fetal Monitoring
- Initial assessment should confirm fetal well-being 1
- Serial ultrasound surveillance including fetal biometry, amniotic fluid assessment, and umbilical artery Doppler 1, 4
- More frequent monitoring if fetal growth restriction is present 4
Timing of Delivery
Deliver at 37 weeks' gestation or earlier if any of the following develop: 1
- Repeated episodes of severe hypertension despite treatment with 3 classes of antihypertensives 1
- Progressive thrombocytopenia 1
- Progressively abnormal renal or liver enzyme tests 1
- Pulmonary edema 1
- Abnormal neurological features (severe headache, visual scotomata, convulsions) 1
- Non-reassuring fetal status 1
For severe pre-eclampsia between 24-34 weeks:
Postpartum Management
- Continue close monitoring for at least 3 days postpartum as eclampsia can still develop 1
- Monitor BP at least every 4 hours while awake 1
- Continue antihypertensives and taper slowly after days 3-6 postpartum 1
- Avoid abrupt cessation of antihypertensive therapy 1
- Review at 3 months postpartum to ensure BP, urinalysis, and laboratory abnormalities have normalized 1
Prevention Strategies for High-Risk Women
Low-dose aspirin (75-162 mg/day) before 16 weeks' gestation (definitely before 20 weeks) for women with strong clinical risk factors: 1
- Prior pre-eclampsia
- Chronic hypertension
- Pre-gestational diabetes
- BMI >30 kg/m²
- Antiphospholipid syndrome
- Assisted reproduction
Supplemental calcium (1.2-2.5 g/day) if intake is likely low (<600 mg/day) 1
Special Considerations
- Home BP monitoring is useful for managing chronic hypertension in pregnancy 1
- Avoid low molecular weight heparin for pre-eclampsia prevention 1
- Women with pre-eclampsia should be counseled about increased lifetime cardiovascular risk 1
- Regular exercise during pregnancy may help reduce the likelihood of hypertension 1